Product Information

TOPIRAMATE 25 MG SPRINKLE CAP is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2445 per EA under NDC 68462021960. Its NADAC has been published 116 times since Aug 28, 2024.

FDA first approved this application on Jul 16, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE 25 MG SPRINKLE CAP

Topiramate
$0.2445per EA

Strength

25 mg/1

NDC

68462021960

Classification

Generic

Dosage Form

CAPSULE, COATED PELLETS

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA217869

FDA Approved

7/16/2024

TE Code

AB

On Market Since

7/16/2024

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE 25 MG SPRINKLE CAP has been published 116 times since Aug 28, 2024, and over the history we have for it it has declined 58.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2445 per EA
All-time high$0.6024 (Oct 16, 2024)
All-time low$0.2445 (Oct 21, 2026)
52-week high$0.4019
52-week low$0.2445
Median price$0.3872
Average price$0.3884
Largest weekly change-25.0% (Nov 20, 2024)
Weeks tracked116
Tracking sinceAug 28, 2024

Price History

1W

0.0%

1M

-0.6%

3M

-9.0%

6M

-19.7%

1Y

-34.0%

3Y

N/A

5Y

N/A

All

-58.3%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOPIRAMATE 25 MG SPRINKLE CAP?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 25 MG SPRINKLE CAP, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2445 per EA (NDC 68462021960), effective Nov 11, 2026.

How has the price of TOPIRAMATE 25 MG SPRINKLE CAP changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE 25 MG SPRINKLE CAP has declined 58.3%. It has been tracked across 116 weekly CMS publications since Aug 28, 2024.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE 25 MG SPRINKLE CAP?

Since Aug 28, 2024, the NADAC for TOPIRAMATE 25 MG SPRINKLE CAP has ranged from a low of $0.2445 (Oct 21, 2026) to a high of $0.6024 (Oct 16, 2024), with a median of $0.3872 per EA.

Are there cheaper alternatives to TOPIRAMATE 25 MG SPRINKLE CAP?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOPIRAMATE 25 MG SPRINKLE CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures TOPIRAMATE 25 MG SPRINKLE CAP?

TOPIRAMATE 25 MG SPRINKLE CAP (NDC 68462021960) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.